Clincosm LogoSign in Get a demo

pulmonary hypertension

Showing 51 - 75 of 505
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BPD - Bronchopulmonary Dysplasia, Pulmonary Hypertension, NEC Trial (L-Citrulline)

Not yet recruiting
  • BPD - Bronchopulmonary Dysplasia
  • +2 more
  • L-Citrulline
  • (no location specified)
Nov 23, 2022

Patients With Kidney Transplantation

Recruiting
  • Pulmonary Hypertension
  • +2 more
  • exercise echocardiography
  • Graz, Austria
    Medical University of Graz, Department of Internal Medicine, Div
Nov 15, 2022

Asthma, COPD, Interstitial Lung Disease Trial in Kansas City (Hyperpolarized Xe129)

Recruiting
  • Asthma
  • +6 more
  • Hyperpolarized Xe129
  • Kansas City, Kansas
    University of Kansas Medical Center
Nov 12, 2022

Pulmonary Hypertension Trial in Zurich

Recruiting
  • Pulmonary Hypertension
    • Zurich, Switzerland
      Respiratory Clinic, University Hospital of Zurich
    Nov 8, 2022

    Pulmonary Hypertension Trial in Calgary (Exercise Intervention, Standard Care)

    Withdrawn
    • Pulmonary Hypertension
    • Exercise Intervention
    • Standard Care
    • Calgary, Alberta, Canada
      Peter Lougheed Centre (PLC), University of Calgary
    Nov 4, 2022

    Sleep Apnea, Obstructive Sleep Apnea, Pulmonary Hypertension Trial in Beijing (Level III portable sleep study)

    Recruiting
    • Sleep Apnea
    • +7 more
    • Level III portable sleep study
    • Beijing, China
      Center for Respiratory and Pulmonary Vascular Diseases, Fuwai ho
    Oct 25, 2022

    Infrastructure, Design and Technology for Early Phase Studies in

    Recruiting
    • Pulmonary Hypertension
    • CardioMEMS HF System
    • Sheffield, South Yorkshire, United Kingdom
      Sheffield Teaching Hospitals NHS Foundation Trust
    Oct 24, 2022

    Infant,Premature, Bronchopulmonary Dysplasia, Pulmonary Hypertension Trial in Salt Lake City (L-Citrulline)

    Terminated
    • Infant,Premature
    • +2 more
    • Salt Lake City, Utah
      University of Utah Health
    Oct 11, 2022

    Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial (Inhaled Treprostinil)

    Available
    • Pulmonary Hypertension
    • +2 more
    • Inhaled Treprostinil
    • (no location specified)
    Oct 5, 2022

    Pulmonary HYpertension

    Recruiting
    • Pulmonary Hypertension
    • Pulmonary Arterial Hypertension
    • Right heart catheterization
    • Beijing, Beijing, China
      Fuwai Hospital, Chinese Academy of Medical Sciences and Peking U
    Sep 30, 2022

    Heart Failure, Pulmonary Hypertension Trial in Vancouver, Ottawa (Rivet Shunt)

    Not yet recruiting
    • Heart Failure
    • Pulmonary Hypertension
    • Rivet Shunt
    • Vancouver, British Columbia, Canada
    • +1 more
    Sep 26, 2022

    Pulmonary Embolism, Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Tucson (Catheter directed

    Recruiting
    • Pulmonary Embolism
    • +2 more
    • Catheter directed therapy
    • Systemic anticoagulation
    • Tucson, Arizona
      Banner University Medical Center
    Sep 21, 2022

    Pulmonary Hypertension, Medication Therapy Management Trial in Beijing

    Not yet recruiting
    • Pulmonary Hypertension
    • Medication Therapy Management
      • Beijing, China
        center of pulmonary vascular disease, Fuwai hospital
      Sep 21, 2022

      Genetics of Pulmonary Hypertension

      Enrolling by invitation
      • Pulmonary Hypertension
        • Ankara, Turkey
          Gazi University School of Medicine
        Sep 19, 2022

        Pulmonary Hypertension Trial in Munich (Occlutech AFR Device)

        Recruiting
        • Pulmonary Hypertension
        • Occlutech AFR Device
        • Munich, Bavaria, Germany
        • +16 more
        Sep 5, 2022

        Pulmonary Hypertension Trial in Israel, Moldova, Republic of, United States (MK-5475, Placebo)

        Completed
        • Pulmonary Hypertension
        • Lexington, Kentucky
        • +8 more
        Aug 24, 2022

        Pulmonary Hypertension Trial in United States (ABI-009, nab-rapamycin, albumin-bound rapamycin)

        Active, not recruiting
        • Pulmonary Hypertension
        • ABI-009, nab-rapamycin, albumin-bound rapamycin
        • Tucson, Arizona
        • +5 more
        Aug 22, 2022

        COPD, Pulmonary Hypertension, COPD Trial in Edegem (Inhaled Nitric Oxide 30mcg/kg IBW/hr)

        Terminated
        • COPD
        • +2 more
        • Inhaled Nitric Oxide 30mcg/kg IBW/hr
        • Edegem, Belgium
          Antwerp University Hospital
        Aug 9, 2022

        Pulmonary Hypertension Trial in Worldwide (Treprostinil Palmitil, Placebo)

        Recruiting
        • Pulmonary Hypertension
        • Treprostinil Palmitil
        • Placebo
        • Los Angeles, California
        • +17 more
        Aug 2, 2022

        ADAMTSL4 in Idiopathic Pulmonary Hypertension and CTEPH

        Completed
        • Pulmonary Hypertension
        • drugs or BPA
        • Chongqing, Chongqing, China
          the First Affiliated Hospital, Chongqing Medical University
        Jul 26, 2022

        Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States

        Completed
        Has Results
        • Pulmonary Hypertension
        • +2 more
        • Inhaled Treprostinil
        • Placebo
        • Birmingham, Alabama
        • +96 more
        Jul 21, 2022

        es to Classify Heart Failure With PReserved Ejection Fraction by

        Completed
        • Heart Failure, Diastolic
        • +3 more
        • RRBS
        • Naples, Italy
          University of Campania Luigi Vanvitelli
        Jul 24, 2022

        Pulmonary Hypertension, COPD Trial in United States (Inhaled NO delivered via INOpulse DS-C Device, Placebo delivered via

        Completed
        • Pulmonary Hypertension
        • Chronic Obstructive Pulmonary Disease
        • Inhaled NO delivered via INOpulse DS-C Device
        • Placebo delivered via INOpulse DS-C Device
        • Jasper, Alabama
        • +42 more
        Jul 13, 2022

        Pulmonary Arterial Hypertension, Pulmonary Hypertension Trial in Canada, United States (Inhaled Nitric Oxide 0.025 mg/kg IBW/hr

        Completed
        • Pulmonary Arterial Hypertension
        • Pulmonary Hypertension
        • Inhaled Nitric Oxide 0.025 mg/kg IBW/hr delivered via INOpulse DS Device
        • +2 more
        • Birmingham, Alabama
        • +50 more
        Jul 13, 2022

        Pulmonary Hypertension, Connective Tissue Disease Trial in Heidelberg (exercise training)

        Recruiting
        • Pulmonary Hypertension
        • Connective Tissue Disease
        • exercise training
        • Heidelberg, Baden-Wuerttemberg, Germany
          Thoraxclinic at the University Hospital Heidelberg
        Jul 12, 2022